Related Experiment Video
Updated: Aug 17, 2026

Isolation of Mouse Megakaryocyte Progenitors
Published on: May 20, 2021
Different radiosensitive megakaryocytic progenitor cells exist in steady-state human peripheral blood
Ikuo Kashiwakura1, Osamu Inanami, Yoshinao Abe
1Laboratory of Radiological Technology, Hirosaki University School of Health Sciences, 66-1 Hon-cho, Hirosaki, Aomori 036-8564, Japan. ikashi@cc.hirosaki-u.ac.jp
Abstract:
CD34 antigen is a novel marker for human hematopoietic stem/progenitor cells. In the present study, two cell fractions, CD34low and CD34high, were prepared from steady-state human peripheral blood on the basis of CD34 antigen expression. The colony-forming unit megakaryocytes (CFU-Meg) contained in each cell fraction were compared for X-radiation sensitivity and cytokine action. The content of CD34+CD45+ cells in the CD34low and CD34high cell fractions was 74.8% and 88.8%, respectively, and the frequency of thrombopoietin (TPO)-supported CFU-Meg in the CD34low cell fraction was 1.9 times higher than that in CD34high. The CFU-Meg in CD34high were more radiosensitive than those in CD34low, indicating that steady-state human peripheral blood contains different types of CFU-Meg. However, no significant differences were observed between cell fractions in the radiation survival curves of CFU-Meg stimulated by TPO plus cytokines except granulocyte colony-stimulating factor (G-CSF). TPO plus interleukin 3 was the optimal combination for survival of both types of CFU-Meg after X irradiation. The present study also demonstrated that TPO plus G-CSF is able to increase the survival of irradiated CD34low CFU-Meg. These results suggest that two megakaryocytic progenitor populations with different radiosensitivity and cytokine responses are found in steady-state human peripheral blood.
Related Concept Videos
Multipotency of Hematopoietic Stem Cells
Production of Formed Elements
Most HSCs commit to...
Differentiation of Common Myeloid Progenitor Cells
Regulation of Hematopoietic Stem Cells
Lineage Commitment
Hematopoiesis

